Tech Nation + BioTech Nation + Global BioEntrepreneurship
image
Weekly Public Radio Program & Podcast
Episode 26-38 Air Date: September 24, 2026
On this week’s Tech Nation, Moira speaks with Dr. Richard Elwes about his book, “Huge Numbers: A Story of Counting Ambitiously, from 4 ½ to Fish 7”. They discuss what really makes a number “huge,” and how the way we count numbers is intertwined with the way we make sense of the world around us. Then, Founder, President, & CEO Lew Bender shares how Intensity Therapeutics is working to change how chemotherapy is administered to patients, with the hopes of reducing the toll it takes on the body.
Episode 26-37Air Date: September 15, 2026
On this week’s Tech Nation, Moira speaks with journalist and author Barry Werth about how the United States’ pharmaceutical industry came to be. His book, “The Age of Cures: How American Scientists Saved Your Life”, tells the stories of several individuals who managed to revolutionize drug research and development, which gave way to major breakthroughs in medicine. Then, Jeff Liter of Luminary Therapeutics shares how his team is working to make advanced cell therapy easier to access and more affordable.
Episode 26-36 Air Date: September 8, 2026
On this week’s Tech Nation, it’s always nice to have the answers, right? Well… maybe that’s not true! Moira speaks with Columbia Professor Stuart Firestein about his new book, “It Could Be Otherwise: Science in the Age of Uncertainty,” and how we can embrace the not-always-knowing. Then, a potential biotech breakthrough for the treatment of gout - a disease that affects over 13 million people around the United States alone. Dr. James Mackay of Crystalys Therapeutics tells us about their new approach as they enter Phase III trials.
image
BioTech Nation PODCASTS
September 29, 2026
Lew Bender, Founder, President and CEO, Intensity Therapeutics
Dr. Lorn Johnson Interview Podcast
  • What if chemotherapy could be delivered in a focused way, directly to a tumor, and only where it's needed? Intensity Therapeutics Founder, President, & CEO Lew Bender shares how they're working to change how chemotherapy is delivered to solid tumors, personalized for each patient, with the hopes of reducing the toll it takes on the body.

September 22, 2026

Jeff Liter Founder & CEO Luminary Therapeutics

image
This week on BioTech Nation, Jeff Liter of Luminary Therapeutics shares how his team is taking a new approach to advanced cell therapy, in the hopes of making it more accessible and affordable. Rather than formulating a custom treatment using a patient's own cells, they use healthy donor cells that are ready to go. This approach could help more people get treated for cancer and autoimmune diseases like lupus, with just a single dose.
The J.P. Morgan Healthcare Conference 2026
5 Companies Ready to Make A Difference
In San Francisco, biotech entrepreneurs, innovators, and investors from all over the globe are gathering at the 44th Annual J.P. Morgan Healthcare Conference. To coincide with the conference, we’ve put together a special release of 5 BioTech Nation interviews…
These are the JP Morgan Conference 2026 BioTech Nation “5”!
We hear from 5 unique BioTech companies ready to make a difference. Hear their stories directly from the founders, CEOs, and scientists that are making waves in the biotech world:
💡 A New Way to Treat Cancer - Cyriac Roeding & Dr. David Suhy, Earli
💡 A Speedy Intervention for Heart Attacks - Dr. Harry Selker & Atul Deshpande Ph.D., MBA, A-PMP, IMMEDIATE Therapeutics
💡 A Fast-Acting Dupixent? - Dr. Barry Quart, Connect Biopharma
💡 You’ve Had Back Pain for 7-10 Years?- Neil Klompas, Augurex Life Sciences Corp.
💡 A Euphoria-Suppressing Opioid - Ketan Mehta, Tris Pharma
image
image
Industry Insights. Startup Directory. Academic Journal. More Information coming soon.